Summary:
Help Protect Against RSV
There are currently no approved treatments of vaccines for RSV. The ConquerRSV Trial is studying an investigational vaccine to help your body’s immune system protect against RSV.
This clinical trial is looking for adult volunteers. To join, you must be:
- 60 years of age or older
- In good health
- Certain chronic diseases such as heart failure and chronic obstructive pulmonary disease may be permissible
- Primarily responsible for self-care (do not require a caretaker)
By participating in this clinical trial, you could potentially change the future of RSV.
Learn more about participating in the ConquerRSV Trial, a clinical trial for a potential vaccine to prevent respiratory syncytial virus (RSV) infection. RSV is a common respiratory virus that infects the lungs and breathing passages and is the second leading cause of significant respiratory tract illnesses in adults, only behind influenza (flu).